At what age should a postmenopausal woman with a significant smoking history and possible history of hormone replacement therapy (HRT) start getting Dual-Energy X-ray Absorptiometry (DEXA) screenings for osteoporosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

DEXA Screening for Osteoporosis in Postmenopausal Women

For a postmenopausal woman with significant smoking history, begin DEXA screening now if she is age 65 or older, or immediately at any age under 65 if her 10-year fracture risk equals or exceeds 9.3% (equivalent to a 65-year-old white woman without risk factors). 1

Age-Based Screening Thresholds

Women Age 65 and Older

  • All women age 65 and older should undergo routine DEXA screening of the hip and lumbar spine, regardless of other risk factors. 1, 2, 3
  • This is a Grade B recommendation with strong evidence that screening and treatment reduce fracture risk and associated morbidity and mortality. 1, 3

Women Under Age 65

  • Screen postmenopausal women younger than 65 years if their fracture risk equals or exceeds that of a 65-year-old white woman without additional risk factors (9.3% 10-year fracture risk). 1, 2
  • Smoking is a major risk factor that significantly increases fracture risk, particularly in women. 1, 4

Risk Assessment Algorithm for Women Under 65

Step 1: Identify Major Risk Factors

Key risk factors beyond postmenopausal status include: 1

  • Cigarette smoking (your patient has this)
  • Low body weight (< 70 kg or BMI < 21 kg/m²)
  • Parental history of hip fracture
  • Excess alcohol consumption (daily use)
  • History of hormone replacement therapy (HRT) discontinuation

Step 2: Calculate FRAX Score

  • Use the FRAX tool to estimate 10-year fracture risk using age, BMI, smoking status, and other clinical factors. 1
  • The tool does not require prior DEXA results to calculate risk. 1
  • A 10-year fracture risk ≥9.3% warrants DEXA screening. 1

Step 3: Examples of High-Risk Profiles Requiring Screening

Women under 65 who meet the 9.3% threshold include: 1

  • Age 50: current smoker with BMI < 21 kg/m², daily alcohol use, and parental fracture history
  • Age 55: parental fracture history alone
  • Age 60: BMI < 21 kg/m² and daily alcohol use
  • Age 60: current smoker with daily alcohol use

Screening Methodology

Preferred Test

  • DXA of the hip and lumbar spine is the gold standard screening test. 1, 2, 3
  • Bone density measured at the femoral neck by DXA is the best predictor of hip fracture. 1, 3
  • DXA uses low radiation doses and correlates with bone strength and clinical fracture outcomes. 1

Diagnostic Threshold

  • Osteoporosis is defined as a T-score ≤ -2.5 at the hip or lumbar spine. 1

Screening Intervals

  • Minimum 2 years between repeat DEXA scans is needed to reliably measure changes in bone mineral density. 1, 2, 3
  • Longer intervals (every 2-3 years for normal BMD) may be adequate for repeated screening. 2, 3
  • Women with normal BMD at age 65 may not transition to osteoporosis for almost 17 years. 2
  • Higher-risk women (lower baseline BMD, additional risk factors) benefit from more frequent screening. 1, 3

Critical Considerations for Your Patient

Smoking as a Risk Factor

  • Smoking risk is proportionately higher in women than men, making cessation particularly important. 4
  • Smoking cessation should be strongly encouraged regardless of age, with benefits seen within 6 months. 4
  • Use the "Five As" approach: Ask, Advise, Assess, Assist, Arrange follow-up. 4

HRT History

  • Discontinuation of HRT increases fracture risk and should be factored into screening decisions. 1
  • Low weight and no current estrogen therapy are incorporated into risk assessment tools. 1

Common Pitfalls to Avoid

  • Do not wait until age 65 to screen if significant risk factors are present. 1 The USPSTF 9.3% threshold has low sensitivity (24-37%) for detecting osteoporosis in younger women, meaning many cases are missed if screening is delayed. 5
  • Do not use BMI alone for screening decisions, though BMI < 28 kg/m² has reasonable sensitivity (95%) for detecting osteoporosis in postmenopausal women ages 50-64. 6
  • Do not repeat DEXA scans more frequently than every 2 years unless clinically indicated, as precision limitations prevent reliable measurement of change. 1, 2
  • Do not overlook that advancing age is a stronger determinant of fracture risk than bone density alone due to declining bone quality and increased fall risk. 1

Practical Implementation

For your specific patient with smoking history and possible HRT use:

  1. Calculate her FRAX score immediately using current age, BMI, smoking status, and other risk factors. 1
  2. If FRAX score ≥9.3% or if she is age 65+, order DEXA of hip and lumbar spine now. 1, 2
  3. Initiate smoking cessation counseling with pharmacological support if needed. 4
  4. Ensure adequate calcium (1000-1200 mg daily) and vitamin D (800-1000 IU daily) intake. 3
  5. Implement fall prevention strategies and weight-bearing exercise. 4, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Osteoporosis Screening Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Osteoporosis Screening and Management in Women Aged 65-85 Years

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Smoking Cessation for Osteoporosis Risk Reduction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

US Preventative Services Task Force FRAX threshold has a low sensitivity to detect osteoporosis in women ages 50-64 years.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2015

Related Questions

Is a Dual-Energy X-ray Absorptiometry (DEXA) scan still recommended for an 86-year-old female?
At what age should we start a Dual-Energy X-ray Absorptiometry (DEXA) scan?
What is the recommended timing for a follow-up Dual-Energy X-ray Absorptiometry (DEXA) scan for a 50-year-old perimenopausal female with osteopenia?
When should a 50-year-old postmenopausal woman with risk factors for osteoporosis have her next DEXA scan?
At what age do Dual-Energy X-ray Absorptiometry (DEXA) scans typically start for osteoporosis screening?
What is the management of paralytic ileus in pediatric patients?
What is the next step in managing a 70-year-old male patient with a history of compression fracture, muscle weakness, bradycardia, diabetes, chronic obstructive pulmonary disease (COPD), dysphasia, cerebral vascular accident (CVA), falls, vascular dementia, post-traumatic stress disorder (PTSD), anxiety, suicidal ideation, constipation, aortic heart disease, hypertension, and orthostatic hypotension, who is currently taking Humalog (insulin lispro) insulin, citalopram, metformin, and a statin, and amlodipine 10mg and folate 1mg daily, with uncontrolled morning blood pressure readings ranging from 131/62 to 188/75 and a pulse ranging from 45 to 60?
What is the treatment for a patient with a ruptured umbilical hernia?
What is the most appropriate initial investigation for a patient presenting with daytime sleepiness, nocturia, orthopnea, bilateral lower limb (BL LL) edema, high blood pressure (hypertension), and low oxygen saturation (hypoxemia), with a clear chest?
What supplements are recommended for a patient with bone spurs, possibly with a background of osteoarthritis?
What is the management approach for a patient with a positive Mitochondria M2 antibody (IgG) result, suggestive of Primary Biliary Cholangitis (PBC)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.